ArticleMolecular neurobiology2026
Microplastic-Induced Disruption of Intestinal Barrier Integrity and Triggering Neuroinflammatory Responses Through Gut-Brain Axis Dysregulation Mediated by NF-κB/PPAR-γ/BDNF Signalling Pathways.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microplastics (MPs) are emerging environmental contaminants increasingly implicated in intestinal dysfunction and neuroinflammatory alterations through gut-brain axis (GBA) dysregulation. However, the mechanistic involvement of polyethylene (PE) and polypropylene (PP) MPs in GBA-associated neurotoxicity remains insufficiently understood. Therefore, the present study aimed to evaluate the impact of PE- and PP-MPs on intestinal barrier integrity, oxidative stress, neuroinflammation, and synaptic dysfunction. Following physicochemical characterization, experimental animals were orally exposed to PE- and PP-MPs (10 and 100 mg/kg BW) for 45 consecutive days. MP exposure significantly disrupted intestinal barrier integrity, reduced zonula occludens-1 expression, and altered short-chain fatty acid profiles, indicating impaired gut microbial metabolic activity. Concurrently, oxidative stress and inflammatory responses were evidenced by reduced antioxidant defence, increased lipid peroxidation, elevated inflammatory mediators, and altered neurochemical markers in small intestine and brain tissues. Behavioral abnormalities, increased amyloid precursor protein (APP) expression, tau-associated pathological alterations, and histopathological changes further indicated GBA impairment following MP exposure. Notably, PE-MPs produced comparatively greater toxicological effects than PP-MPs, particularly at higher dose. Overall, the findings demonstrate that chronic exposure to environmentally relevant PE- and PP-MPs disrupts intestinal homeostasis and promotes neuroinflammatory toxicity through GBA dysregulation.
Indexed as
Identifiers
42406299What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.